MMP9 and airway hyperresponsiveness: In vitro and in vivo assays also determined that MMP9 significantly reduces RSV replication, host cell viability, airway hyperresponsiveness (AHR), body weight loss and enhances RANTES, IL-1β, SCF and G-CSF production during RSV infection.